What patient factors most strongly influence your decision to start biologic agents in mild cognitive impairment?
Specifically, what guidelines do you use to help determine this (if any)?
Answer from: at Academic Institution
1.Absence of need for anticoagulants ( this is exclusionary)
2. Absence of APOE e4 homozygosity (although we do treat e4 homozygotes, but with much greater precautionary measures - especially the dosing protocol)
3. High functional ability, and adherence to healthy lifestyle measures (exerci...